title: GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.
abstract: Deletions of 1p occur in approximately 30% of meningiomas. Based on loss of heterozygosity (LOH) analysis, two regions on 1p have been suspected to be carriers of tumor suppressor genes. We chose the GADD45A and EPB41 genes as tumor suppressor candidates based on their function and chromosomal localization. We analyzed 19 cases of meningioma with LOH of 1p by means of sequencing of the GADD45A gene and Western blotting of the GADD45a protein. Twenty cases of meningioma without 1p LOH were also analyzed by Western blotting to find out if changes of the GADD45a protein expression occurred. Nineteen samples with 1p LOH (12 grade I; 7 grade II, WHO classification) and 20 samples without 1p LOH (18 grade I; 2 grade II) were also analyzed by means of real-time polymerase chain reaction to find abnormalities in EPB41 mRNA levels in meningioma. LOH analysis was performed using seven microsatellite markers: D1S508 (1p36.2), D1S199 (1p36.1) D1S2734 (1p36.1), D1S2720 (1p34), D1S197 (1p32), D1S162 (1p32), D1S429 (1p11). LOH analysis confirmed previously described localization of putative tumor suppressor genes on 1p and involvement in meningioma pathogenesis (1p36 and 1p32). The open reading frame of GADD45A and intron splicing sites showed neither mutations nor polymorphisms. GADD45a protein molecular weight and expression level were unaltered in meningiomas with and without 1p LOH. We conclude that the GADD45A gene is not involved in meningioma tumorigenesis. EPB41 gene expression was unchanged in all analyzed meningiomas. This suggests that involvement of the EPB41 gene (4.1R protein) in meningioma pathogenesis should be reconsidered.
authors.affiliation: Department of Molecular Pathology and Neuropathology, Chair of Oncology, Medical University, Czechoslowacka st. 8/10, 92-216 Lodz, Poland.
authors.forename: S
authors.initials: S
authors.lastname: Piaskowski
authors.forename: P
authors.initials: P
authors.lastname: Rieske
authors.forename: M
authors.initials: M
authors.lastname: Szybka
authors.forename: K
authors.initials: K
authors.lastname: Wozniak
authors.forename: A
authors.initials: A
authors.lastname: Bednarek
authors.forename: E
authors.initials: E
authors.lastname: Płuciennik
authors.forename: D
authors.initials: D
authors.lastname: Jaskolski
authors.forename: B
authors.initials: B
authors.lastname: Sikorska
authors.forename: Pawel Piotr
authors.initials: PP
authors.lastname: Liberski
mesh_terms: D001798:Blood Proteins / Q000235:genetics*; D018797:Cell Cycle Proteins / Q000235:genetics*; D002878:Chromosomes, Human, Pair 1; D003598:Cytoskeletal Proteins; D016147:Genes, Tumor Suppressor; D006801:Humans; D019656:Loss of Heterozygosity; D008565:Membrane Proteins; D008577:Meningeal Neoplasms / Q000235:genetics*; D008579:Meningioma / Q000235:genetics*; D008869:Microtubule-Associated Proteins / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics*; D016133:Polymerase Chain Reaction; D000097642:GADD45 Proteins
chemical_list: D001798:Blood Proteins; D018797:Cell Cycle Proteins; D003598:Cytoskeletal Proteins; D008565:Membrane Proteins; D008869:Microtubule-Associated Proteins; D009687:Nuclear Proteins; C439070:GADD45A protein, human; D000097642:GADD45 Proteins; C028841:erythrocyte membrane band 4.1 protein